News, views and contacts from the global Pharmaceutical industry

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

September 2016

Top

Sanaria receives FDA fast-track designation for malaria vaccine 23 September 2016 Sanaria has received fast-track designation from the US Food and Drug Administration (FDA) for candidate malaria vaccine...

EC grants marketing authorisation for Allergan’s Truberzi to treat IBS-D 23 September 2016 The European Commission (EC) has granted marketing authorisation for Allergan’s Truberzi (eluxadoline) in...

M&As this week: Allergan, Walvax Biotechnology 23 September 2016 Allergan plans to develop novel treatments for non-alcoholic steatohepatitis (NASH) and other liver diseases through the acquisition of Akarna Therapeutics. The acquisition has been completed for...

Report: Favourable market environment to drive Australian pharmaceutical industry to $25bn by 2020 23 September 2016 Good market access and government’s welfare reforms such as subsidies for prescription drugs are expected to drive the pharmaceutical market in Australia to $25bn in value by 2020, according to...

Deals this week: Bayer AG, Plasticell, Sarepta Therapeutics 23 September 2016 Bayer AG and Evotec AG have entered a multi-target research partnership agreement to develop novel treatments for chronic kidney disease in diabetic...

EMA confirms safety of plasma and urine-derived medicines from Zika virus contamination 22 September 2016 The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has confirmed that plasma or urine-derived medicines are safe for use in...

CRT and SV Life Sciences set up Artios Pharma to develop drugs targeting DNA damage response in cancer 22 September 2016 Cancer Research UK's development and commercialisation unit Cancer Research Technology (CRT) and SV Life Sciences have established a company called Artios Pharma to develop drugs targeting the...

US FDA approves Janssen's Invokamet XR for type 2 diabetes treatment in adults 22 September 2016 The US Food and Drug Administration (FDA) has granted approval for Janssen Pharmaceuticals' Invokamet XR to treat type 2 diabetes in...

Major pharmaceutical companies present new roadmap to combat anti-microbial resistance 21 September 2016 Major global pharmaceutical companies have published a new roadmap at a UK Government Department of Health event, aimed to combat anti-microbial resistance...

BioNTech and Genentech partner to develop individualised mRNA cancer therapies 21 September 2016 German biotechnology company BioNTech has agreed to collaborate with Roche’s Genentech to develop and commercialise messenger ribonucleic acid (mRNA) based, individualised cancer...

Sarepta Therapeutics receives FDA approval for Exondys 51 to treat DMD 20 September 2016 US-based biopharmaceutical company Sarepta Therapeutics has secured the US Food and Drug Administration (FDA) accelerated approval for its Exondys 51 (eteplirsen) as a once-weekly...

Zydus Cadila and Takeda partner to develop vaccine for Chikungunya virus 20 September 2016 Indian healthcare provider Zydus Cadila and Takeda Pharmaceutical have agreed to partner to develop a vaccine for an emerging infectious disease known as...

GE to invest €150m to build biopharmaceutical manufacturing campus in Ireland 19 September 2016 GE plans to invest €150m in a new biopharmaceutical manufacturing campus on Industrial Development Agency's site (IDA) at Loughbeg, Ringaskiddy, Co. Cork,...

EMA grants positive opinion for Takeda’s NINLARO to treat multiple myeloma in adult patients 19 September 2016 European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion recommending the conditional approval of Takeda Pharmaceutical's...

Cesca Therapeutics receives two patents for rapid infusion of autologous bone marrow derived stem cells 19 September 2016 United States Patent & Trademark Office (USPTO) has granted Cesca Therapeutics the first two of a family of patent applications related to its proprietary methods for the treatment of...

Ontario provides shingles vaccine to its senior citizens for free 16 September 2016 The Canadian province of Ontario is providing the shingles vaccine free of charge to 850,000 people aged between 65 and 70 years old, as part of its publicly funded immunisation...

FDA approves Shire’s Cuvitru treatment in adult and paediatric patients 16 September 2016 The US Food and Drug Administration (FDA) has granted approval for Shire’s Cuvitru treatment in adult and paediatric patients aged two years and...

M&As this week: Duran Group, Catalent Pharma Solutions 16 September 2016 Duran Group has entered an agreement to acquire Kimble Chase Life Sciences & Research Products from Gerresheimer for a purchase consideration of...

Report: Asia-Pacific gastric cancer market to grow to $2.7bn by 2022, but prospects weak for premium pricing 16 September 2016 Increasing prevalence of the disease coupled with growing awareness is set to grow the market for gastric cancer in Asia-Pacific At a double-digit compound annual growth rate (CAGR) of...

Deals this week: Morphotek, PRA Health Sciences, Agios Pharmaceuticals 16 September 2016 Morphotek and Fox Chase Cancer Centre (FCCC) have entered a sponsored research agreement (SRA) to advance research on immunosuppressive effects of tumour shed antigens to develop improvised...

Pfizer launches Moodivator app to help treat depression 15 September 2016 Pfizer has launched a new app, called Moodivator, to help adults who experience...


cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1243308781_ap1243308781_1857678299_874850511